Abstract
10-Imidazolylbornane-2-one bearing a sterically crowded spirocyclic substituent at the C-3 position was prepared from d-camphor through the procedure involving the formation of 10-bromobornane-2-thiones or 10-iodobornane-2-thiones and the subsequent conversion into the corresponding 10-imidazolylbornane-2-thiones followed by an efficient oxidative S-O exchange via thione S-oxides.
Keywords
d-Camphor and its functionalized derivatives have been widely recognized as the versatile substrates for chiral auxiliaries, ligands, and chiral building blocks for asymmetric syntheses due to the commercial availability with the structural stability and chirality, and therefore, a variety of functionalization of bornane skeletons have been extensively studied within these decades. 1 -4 In most cases, preparation of functionalized bornane skeleton bearing functionalities at the C-2 and/or C-3 positions has been carried out via commercially available d-camphor or camphorquinone. On the other hand, rather limited methods for C-10 functionalization are available to us, and camphor-10-sulfonic acid is usually used as the substrates for the further conversion due to the lack of other convenient methods for functionalization at the C-10 position. Therefore, new synthetic methods involving direct regioselective oxidation or halogenation of the C-10 position of the skeleton are keenly required concerning the current requirements in the expansion of their synthetic diversity of the skeleton to a new type of chiral ligands and organocatalysts. Actually, some limited studies concerning the preparation of 10-halobornane derivatives from d-camphor or camphor-10-sulfonic acid have been achieved to date. 5 -17
In the course of our synthetic studies on chiral organosulfur compounds, we have been engaging in the selective halogenation of bornane-2-thiones bearing a highly bulky spirocyclic substituent to afford 10-halobornane-2-thiones

A new synthetic route for 10-imidazolylbornan-2-ones B.
Sterically crowded camphor derivatives
Preparation of 10-Bromobornane-2-thiones 3 and 10-Iodobornane-2-thiones 4.
NIS, N-iodosuccinimide; R.T., room temperature.
Alternatively, conversion of

Preparation of 10-iodobornane-2-thiones (4a-b) by treating 10-bromobornane-2-thiones (3a-b) with NaI.
In general, N-alkylimidazolium salts are prepared through the reaction of N-methylimidazole with an alkylating agent.
8,31,32
However, in our preliminary attempt, reaction of

Plausible base-induced skeletal rearrangement of sterically crowded 10-imidazolylbornane-2-thione 6b.
Reaction of 10-Halobornane-2-thiones (3, 4) with Sodium Hydride and Imidazole.
R.T., room temperature.
Subsequent treatment of
On the other hand, when the isomeric mixture of thione S-oxides (

Synthesis of sterically crowded 10-imidazolylbornan-2-one 9a.
Furthermore, a preliminary attempt of conversion of ketone

Synthesis of N-methylimidazolium salt 10a.
In conclusion, we have achieved a convenient synthesis of 10-imidazolylbornan-2-one (
Experimental
Instruments
Melting points, Barnstead International MEL-TEMP; NMR, Bruker DRX-400P (400 MHz) or Bruker AVANCE III 500 (500 MHz) spectrometer; MS, JEOL JMS-700T mass spectrometer; HRMS, JEOL JMS-700T spectrometer; IR, JASCO FT/IR-7300 spectrometer; elemental analyses were performed using a Yanagimoto CHN corder MT-5.
A Typical Procedure for Preparation of 10-Bromobornane-2-thiones (3a-b) by Treating Thiones 2 with Bromine
A 10 mL CH2Cl2 solution of thione
Physical and Spectral Data for 10-Bromobornane-2-thiones 3
Orange oil.
[α]D 25: +29.2 (c 0.1, CHCl3).
IR (neat): 2951, 1455, 1266, 662 cm−1.
1H NMR (CDCl3) δ: 0.92(3H, s), 1.21 (3H, s), 1.44 (1H, ddd, J = 14.2, 8.5, 5.5 Hz), 1.49-1.79 (6H, m), 1.81-1.96 (6H, m), 2.00 (1H, d, J = 3.6 Hz), 2.21 (1H, ddd, J = 11.4, 8.1, 4.4 Hz), 3.49 (1H, d, J = 11.0 Hz), 3.87 (1H, d, J = 11.0 Hz).
13C NMR (CDCl3) δ: 22.7 (t), 22.8 (t), 26.7 (q), 27.1 (q), 31.3 (dd), 33.6 (dd), 43.2 (t), 45.9 (t), 51.0 (s), 56.9 (d), 67.2 (s), 71.1 (s), 280.0 (s).
MS (m/z): 300 (M+; 61%), 221 (bp).
Calcd for C14H21SBr: C, 55.81; H, 7.03%. Found: C, 55.81; H, 7.17%.
Pale red prisms. MP: 92.6-93.2°C.
[α]D 25: +8.4 (c 0.1, CHCl3).
MS (m/z): 348 (M+; 33%), 142 (bp).
IR (KBr): 2938, 2357, 1488, 1371, 1276, 744 cm−1.
1H NMR (CDCl3) δ: 1.07 (3H, s), 1.26 (3H, s), 1.46 (1H, ddd, J = 14.0, 8.7, 5.2 Hz), 1.87 (1H, ddd, J = 13.1, 9.3, 3.2 Hz), 1.96-2.05 (1H, m), 2.18 (1H, d, J = 3.6 Hz), 2.24 (1H, ddd, J = 13.8, 11.1, 3.2 Hz), 3.17 (1H, d, J = 16.0 Hz), 3.24 (1H, d, J = 16.3 Hz), 3.30 (1H, d, J = 16.3 Hz), 3.40 (1H, d, J = 16.0 Hz), 3.54 (1H, d, J = 11.1 Hz), 3.89 (1H, d, J = 11.1 Hz), 7.10-7.16 (4H, m).
13C NMR (CDCl3) δ: 22.9 (q), 23.1 (q), 23.2 (q), 30.7 (dd), 33.2 (dd), 47.7 (t), 50.7 (s), 51.7 (t), 56.3 (d), 67.5 (s), 71.0 (s), 123.5 (d), 123.7 (d), 126.5 (d), 126.6 (d), 140.7 (s), 141.8 (s), 275.8 (s).
Calcd for C18H21SBr: C, 61.89; H, 6.06%. Found: C, 61.51; H, 6.22%.
A Typical Procedure for Preparation of 10-Iodobornane-2-thiones (4) by Treating thiones 2 with Iodine Monochloride (ICl)
To a 10 mL suspended CH2Cl2 solution of thione
General Procedure for the Synthesis of 10-Iodobornane-2-thiones 4 by Treating 10-Bromobornane-2-thiones 3 with Sodium Iodide (NaI)
A 0.5 mL dry DMF solution of 10-bromobornane-2-thione
Physical and Spectral Data for 10-Iodobornane-2-thiones 4
Orange oil.
[α]D 25: +1.2 (c 0.1, CHCl3).
IR (neat): 2922, 2362, 1458, 1075, 774 cm−1.
1H NMR (CDCl3) δ: 0.88 (3H, s), 1.17 (3H, s), 1.50 (1H, ddd, J = 13.8, 8.5, 5.7 Hz), 1.55-1.76 (6H, m), 1.83-1.94 (4H, m), 1.98-2.12 (2H, m), 3.26 (1H, d, J = 10.4 Hz), 3.50 (1H, d, J = 10.4 Hz).
13C NMR (CDCl3) δ: 6.8 (t), 22.5 (q), 22.6 (q), 22.7 (t), 26.5 (t), 27.0 (t), 34.5 (dd), 42.9 (t), 45.9 (t), 50.8 (s), 57.2 (d), 67.0 (s), 69.4 (s), 279.0 (s).
MS (m/z): 348 (M+; 46%), 221 (M+-I; 37%), 163 (bp).
Calcd for C14H21SI: C, 48.28; H, 6.08%. Found: C, 48.56; H, 6.06%.
Pale red needles. MP: 88.1-89.9°C.
IR (KBr): 2941,2356, 1633, 1479, 1412, 1215, 730 cm−1.
1H NMR (CDCl3) δ: 1.03 (3H, s), 1.22 (3H, s), 1.50-1.56 (1H, m), 1.83-1.88 (1H, m), 1.94-2.00 (1H, m), 2.11-2.16 (1H, m), 2.27 (1H, d, J = 3.5 Hz), 3.17 (1H, d, J = 16.0 Hz), 3.25 (1H, d, J = 16.5 Hz), 3.28 (1H, d, J = 16.5 Hz), 3.31 (1H, d, J = 10.5 Hz), 3.43 (1H, d, J = 16.0 Hz), 3.54 (1H, d, J = 10.5 Hz), 7.10-7.17 (4H, m).
13C NMR (CDCl3) δ: 6.5 (t), 23.0 (q), 23.1 (q), 23.4 (t), 34.1 (dd), 47.6 (t), 50.7 (t), 52.0 (s), 56.7 (d), 67.7 (s), 69.6 (d), 123.7 (d), 123.9 (d), 126.7 (d), 126.8 (d), 140.1 (s), 142.0 (s), 275.2 (s).
MS (m/z): 396 (M+; 82%), 363 (M+-SH; bp), 269 (M+-I; 32%), 235 (M+-HI-S; 56%).
HRMS Calcd for C18H21SI: m/z 396.0409. Found: m/z 396.0409.
Physical and Spectral Data for Rearrangement Products 5
Colorless oil.
IR (neat): 2938, 2357, 1488, 1371, 1276, 744 cm−1.
1H NMR (CDCl3) δ: 1.09 (6H, s), 1.19 (6H, s), 1.28-1.32 (2H, m), 1.47-1.77 (20H, m), 2.01-2.09 (2H, m), 2.38-2.45 (2H, m), 4.79 (2H, s), 5.09 (2H, s).
13C NMR (CDCl3) δ: 24.5 (t), 25.0 (t), 27.3 (t), 29.9 (q), 30.5 (q), 31.5 (t), 31.6 (t), 33.8 (t), 41.6 (s), 55.0 (d), 63.7 (s), 65.2 (s), 102.5 (br. t), 166.1 (s).
MS (m/z): 442 (M+; 28%), 253 (M+-C14H21; 8%), 221 (M+/2; 68%), 95 (bp).
Calcd for C28H42S2: C, 75.95; H, 9.56%. Found: C, 75.51; H, 9.80%.
Yellow oil.
IR (neat): 2927, 1716, 1659, 1462, 1384, 1284, 1221, 1140, 1090, 891, 745 cm−1.
1H NMR (CDCl3) δ: 1.16 (6H, s), 1.28 (6H, s), 1.81-1.85 (8H, m), 2.07 (2H, s), 2.25-2.34 (4H, m), 2.93 (2H, d, J = 15.8 Hz), 3.00 (2H, d, J = 16.2 Hz), 3.06 (2H, d, J = 15.8 Hz), 3.11 (2H, d, J = 16.2 Hz), 4.95 (2H, s), 5.30 (4H, d, J = 7.4 Hz), 7.14-7.17 (8H, m).
13C NMR (CDCl3) δ: 25.0 (q), 29.5 (q), 33.8 (t), 38.8 (t), 39.8 (t), 56.2 (t), 63.6 (s), 63.8 (s), 104.4 (t), 124.0 (d), 124.2 (d), 126.6 (d), 126.7 (d), 141.6 (s), 142.9 (s), 163.1 (s).
MS (m/z): 538 (M+; 9%), 269 (M+/2; bp), 237 (M+/2-S; 11%).
HRMS Calcd for C36H42S2: m/z 538.2728. Found: m/z 538.2826.
A Typical Procedure for the Synthesis of 10-Imidazolylbornane-2-thiones 6 by Treating 10-Bromobornane-2-thiones (3a-b) with Imidazole
A dry hexane solution of imidazole (200 mg, 2.94 mmol, 1.5 mol amt.) was treated with commercial NaH (50 wt% in mineral oil, 140 mg, 2.94 mmol, 1.5 mol amt.) at R.T. for 5 minutes, and then, the reaction mixture was treated with a 2 mL dry DMF solution of 10-bromobornane-2-thione s
A Typical Procedure for the Synthesis of 10-Imidazolylbornane-2-thiones 6 by Treating 10-Iodobornane-2-thione (4a-b) with Imidazole
A dry hexane solution of imidazole (259 mg, 3.81 mmol, 1.5 mol amt.) was treated with commercial NaH (50 wt% in mineral oil, 187 mg, 3.81 mmol, 1.5 mol amt.) at R.T. for 5 minutes, and then, the reaction mixture was treated with a 5 mL dry DMF solution of 10-iodobornane-2-thione
Physical and Spectral Data for 10-Imidazolylbornane-2-thiones 6
Colorless needles. MP: 103.7-104.6°C.
IR (KBr): 3088, 2945, 1700, 1501, 1244, 740 cm−1.
1H NMR (CDCl3) δ: 0.86 (3H, s), 1.13 (3H, s), 1.23-1.26 (1H, m),
1.60-1.98 (13H, m), 4.07 (1H, d, J = 15.2 Hz), 4.52 (1H, d, J = 15.2 Hz), 7.00 (1H, s), 7.04 (1H, br. s), 7.56 (1H, br. s).
13C NMR (CDCl3) δ: 21.0 (t), 22.2 (q), 22.4 (q), 26.5 (t), 27.0 (t), 29.6 (t), 43.4 (d), 45.9 (t), 46.2 (t), 49.8 (s), 56.5 (d), 67.1 (s), 72.4 (s), 129.8 (d), 128.5 (d), 138.4 (d), 281.8 (s).
MS (m/z): 288 (M+; bp), 255 (M+-SH; 32%). 150 (32%).
HRMS Calcd for C17H24N2S: m/z 288.1660. Found: m/z 288.1663.
Calcd for C17H24N2S: C, 70.79; H, 8.39; N, 9.71%. Found: 70.54. H, 8.11, N, 9.51%.
Pale brown oil.
MS (m/z): 336 (M+; 62%), 303 (M+-SH; bp), 179 (26%).
IR (neat): 2935, 1496, 1276, 749, 667 cm−1.
1H NMR (CDCl3) δ: 1.00 (3H, s), 1.09 (3H, s), 1.24-1.29 (3H, m), 1.83-1.94 (4H, m), 1.95-2.17 (1H, br. s), 3.18-3.40 (4H, m), 4.15 (1H, d, J = 15.2 Hz), 4.55 (1H, d, J = 15.2 Hz), 7.00 (1H, s), 7.06 (1H, s), 7.11-7.18 (4H, m), 7.62 (1H, s).
13C NMR (CDCl3) δ: 21.2, 22.4, 23.0, 29.2, 29.6, 46.4, 47.9, 49.6, 51.5, 56.0, 67.4, 72.6, 121.1, 123.4, 123.7, 126.5, 127.9, 138.4, 140.4, 141.6, 277.0.
HRMS Calcd for C21H24N2S: m/z 336.1660. Found: m/z 336.1648.
Pale brown oil.
1H NMR (CDCl3) δ (partially listed data): 1.12 (6H, s), 1.24 (3H, s), 1.40 (3H, s), 2.61 (1H, d, J = 12.0 Hz), 2.80 (1H, d, J = 12.0 Hz), 3.30 (1H, d, J = 13.5 Hz), 3.90 (1H, s), 4.11 (1H, s), 5.793 (1H, s), 5.797 (1H, s), 6.728 (1H, s), 6.731 (1H, s).
MS (m/z): 674 (M+; 1%), 673 (M+-1; 2%), 337 (M+/2; bp).
Synthesis of a Geometrical Mixture of 10-Imidazolylbornane-2-thione S-Oxides 8 by Treating 10-Imidazolylbornane-2-thione 7a with mCPBA
A 25 mL CH2Cl2 solution of 10-imidazolylbornane-2-thione
Physical and Spectral Data for 10-Imidazolylbornane-2-thione S-Oxides 8a and 8a′
Yellow needles.
MP: 135.1-136.1°C.
IR (KBr): 3102, 2940, 1726, 1504, 1444, 1369, 1235, 1044, 753, 662 cm−1.
1H NMR (CDCl3) δ: 0.89 (3H, s), 0.94 (3H, s), 1.18-1.88 (13H, m), 2.04-2.17 (1H, m), 4.87 (2H, s), 7.15 (1H, s), 7.16 (1H, s), 7.62 (1H, s).
13C NMR (CDCl3) δ: 19.5 (t), 22.6 (q), 22.8 (q), 26.2 (t), 26.3 (t), 31.1 (t), 44.3 (d), 45.2 (t), 46.9 (t), 51.1 (s), 56.8 (s), 59.0 (s), 67.2 (s), 120.8 (d), 128.9 (d), 138.4 (d), 215.1 (s).
MS (m/z): 304 (M+; bp), 288 (M+-O; 39%), 255 (M+-O-SH; 60%).
HRMS Calcd for C17H24N2OS: m/z 304.1609. Found: m/z 304.1612.
Yellow needles. MP: 138.0-139.0°C.
IR (KBr): 3096, 2946, 1725, 1507, 1450, 1366, 1233, 1038, 739, 656 cm−1.
1H NMR (CDCl3) δ: 0.97 (3H, s), 1.13 (3H, s), 1.68-2.28 (13H, m), 2.52-2.57 (1H, m), 4.07 (1H, d, J = 14.8 Hz), 4.19 (1H, d, J = 14.8 Hz), 6.96 (1H, s), 7.06 (1H, s), 7.50 (1H, s).
13C NMR (CDCl3) δ: 20.7 (t), 22.5 (q), 22.6 (q), 26.8 (t), 27.3 (t), 32.2 (t), 38.0 (d), 39.8 (t), 46.1 (t), 51.2 (s), 56.5 (s), 59.1 (s), 61.2 (s), 120.4 (d), 129.5 (d), 138.3 (t), 215.6 (s).
MS (m/z): 304 (M+; bp), 288 (M+-O; 94%), 255 (M+-O-SH; 70%).
HRMS Calcd for C17H24N2OS: m/z 304.1609. Found: m/z 304.1607.
General Procedure for the Conversion of an Isomeric Mixture of 10-Imidazolylbornane-2-thione S-Oxides (8a, 8a′ ) into 10-Imidazolylbornan-2-one 9a
A 3 mL methanolic solution of an isomeric mixture of thione S-oxides (
Physical and Spectral Data for 10-Imidazolylbornan-2-one 9a
Pale brown solids.
MS (m/z): 272 (M+; bp), 244 (M+-C2H4; 15%), 150 (31%).
IR (neat): 2958, 1731, 1499, 1267, 1076, 803, 666 cm−1.
1H NMR (CDCl3) δ: 0.86 (3H, s), 1.06 (3H, s), 1.24-1.29 (1H, m), 1.55-1.89 (13H, m), 3.87 (1H, d, J = 12.0 Hz), 4.14 (1H, d, J = 12.0 Hz), 6.99 (1H, s), 7.06 (1H, s), 7.53 (1H, s).
13C NMR (CDCl3) δ: 20.6 (t), 22.2 (q), 22.6 (q), 26.7 (t), 26.8 (t), 27.0 (t), 38.3 (d), 39.5 (t), 43.9 (t), 47.2 (s), 55.0 (d), 56.4 (s), 62.4 (s), 120.9 (d), 128.9 (d), 138.5 (d), 223.8 (s).
HRMS Calcd for C17H24N2O: m/z 272.1889. Found: m/z 272.1890.
Conversion of Ketone 9a into N-Methylimidazolium Salt 10a
A 5 mL THF solution of ketone
Physical and Spectral Data for N-Methylimidazolium Salt 10a
Pale brown solids.
MP: 132.0-134.5°C.
1H NMR (CDCl3) δ: 0.92 (3H, s), 1.24 (3H, s), 1.58-2.04 (19H, m), 2.05-2.16 (1H, m), 4.10 (3H, s), 4.35 (1H, d, J = 16.0 Hz), 4.46 (1H, d, J = 16.0 Hz), 7.44 (1H, s), 7.83 (1H, s), 10.13 (1H, s).
Footnotes
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
